maccura

Stheadline · Apr 20 at 05:06 PM

With the new AI concept stocks, it is "extremely difficult" to hit the mark. Pay attention to the mechanism for setting back calls. See expert estimates of potential gains｜Star Market Strategy

Wallstreetcn · Jan 25 at 11:15 PM

The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%

Zhitong · Oct 24, 2025 at 07:19 AM

Maccura released its performance for the first three quarters, with a net profit attributable to the parent company of 37.1034 million yuan, a decrease of 86.81%

Zhitong · Jul 31, 2025 at 05:22 AM

Maccura released its performance for the first half of the year, with a net profit attributable to the parent company of 34.0425 million yuan, a decrease of 83.12%

Zhitong · Jul 16, 2025 at 05:50 AM

Maccura has obtained multiple medical device registration certificates

Zhitong · Jul 1, 2025 at 08:25 AM

Maccura pays supplementary taxes, expected to impact annual net profit attributable to shareholders by 21.2815 million yuan